Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

China's Diabetes-Drug Market to Reach $2 Billion by 2019, Datamonitor Says
Bloomberg
Monday, November 22, 2010 - 10:20am
tags:
diabetes, China
Novartis denies cost-cutting reports
MarketWatch
Sunday, November 21, 2010 - 1:46pm
tags:
Novartis
Bristol-Myers Squibb Sued for Denying Employees Overtime Pay
PR-USA.net
Sunday, November 21, 2010 - 1:45pm
tags:
Bristol-Myers Squibb, lawsuits
Two Biotechs Fail to IPO: GM’s Offering Dwarfs All Others in Busy Deal Week
Seeking Alpha
Sunday, November 21, 2010 - 1:43pm
tags:
Anacor, Zogenix
Pharma becomes target for organised crime
Financial Times, UK
Sunday, November 21, 2010 - 1:40pm
tags:
Roche Open to Small, Medium-Sized Deals, SonntagsZeitung Says
Bloomberg
Sunday, November 21, 2010 - 1:39pm
tags:
Roche, M&A
Do-It-Yourself Drug Injections May Let CSL Top Baxter in $5 Billion Market
Bloomberg
Sunday, November 21, 2010 - 1:38pm
tags:
Hizentra, CSL, Baxter International
Alnylam Caught Off-Guard by Roche Decision to Drop Alliance
Seeking Alpha
Sunday, November 21, 2010 - 1:36pm
tags:
Alnylam, Roche, gene silencing
Biotech Sector Weekly Rewind
The Street
Saturday, November 20, 2010 - 1:37pm
tags:
biotech
VYTORIN(R) (ezetimibe/simvastatin) Significantly Reduced Major Vascular Events in Patients With Chronic Kidney Disease in a New 9,000-Patient Investigational Study
MarketWatch
Saturday, November 20, 2010 - 1:35pm
tags:
Vytorin, Merck, chronic kidney disease
Dr Reddy's launches anti-asthma tablets in US
Sify, India
Saturday, November 20, 2010 - 1:19pm
tags:
Dr Reddy's, Zafirlukast, asthma
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Medical News Today
Saturday, November 20, 2010 - 1:17pm
tags:
Aeterna Zentaris, AEZS-129, AEZS-132, cancer, melanoma, lung cancer, prostate cancer, colon cancer, breast cancer, endometrial cancer
Cardinal Health to buy pharmaceutical distributor Kinray for $1.3 billion
Pharmabiz
Saturday, November 20, 2010 - 12:53pm
tags:
Cardinal Health, Kinray
Clarus Therapeutics Files To Sell Up To $86.3M In Shares In IPO
WSJ
Saturday, November 20, 2010 - 12:47pm
tags:
Clarus Therapeutics, OriTex, testosterone
Helix BioPharma Corp. Provides Update on Phase II/III IND Application for Topical Interferon Alpha-2b
MarketWatch
Saturday, November 20, 2010 - 12:46pm
tags:
Helix BioPharma, topical interferon Alpha-2b, cervical lesions, cervical cancer
Merck Wins Another Federal FOSAMAX® (alendronate sodium) Bellwether Trial
Yahoo/BusinessWire
Saturday, November 20, 2010 - 12:41pm
tags:
Merck, Fosamax, lawsuits
Why Brazil’s Pharmerging Market Can’t Be Ignored
Seeking Alpha
Saturday, November 20, 2010 - 12:35pm
tags:
Brazil
Scrutiny of Big Pharma set to intensify (In UK)
Financial Times, UK
Saturday, November 20, 2010 - 12:34pm
tags:
Big Pharma
Names You Need To Know: Pradaxa and Xarelto
Forbes
Saturday, November 20, 2010 - 12:24pm
tags:
Boehringer Ingelheim, Bayer, JNJ, Pradaxa, Xarelto, blood thinners
One Drug, Two Names, Two Wildly Different Prospects
Motley Fool
Saturday, November 20, 2010 - 12:22pm
tags:
Amgen, Prolia, Xgeva, denosumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.